Paperpal Prime Logo

Current Pharmaceutical Biotechnology : Impact Factor & More

eISSN: 1873-4316pISSN: 1389-2010

Key Metrics

CiteScore
4.2
H-Index
94
Impact Factor
< 5
SJR
Q2Biotechnology
SNIP
0.74
Recommended pre-submission checks
Powered by Paperpal by Editage

Topics Covered on Current Pharmaceutical Biotechnology

Current Pharmaceutical Biotechnology Journal Specifications

Overview
Publisher BENTHAM SCIENCE PUBL LTD
Language English
Frequency Monthly
General Details
LanguageEnglish
FrequencyMonthly
Publication Start Year2000
Publisher URLVisit website
Website URLVisit website
View less

Planning to publish in Current Pharmaceutical Biotechnology ?

Upload your Manuscript to get

  • Degree of match
  • Common matching concepts
  • Additional journal recommendations
Free Report

Recently Published Papers in Current Pharmaceutical Biotechnology

Protection of Fulvic Acid Against 5-Fluorouracil-induced Intestinal Injury in Mice.
  • 27 Jul 2026
  • Current pharmaceutical biotechnology
Phytochemicals as Novel Antifungal Agents Against Candida species.
  • 25 Jul 2026
  • Current pharmaceutical biotechnology
Ultraviolet-A-Enhanced Antibacterial Activities on Gentamicin-Resistant Escherichia coli by Silver Nanorods Synthesized from Callistemon viminalis Leaf Extract.
  • 23 Jul 2026
  • Current pharmaceutical biotechnology
Challenges and Strategies in Advancing miRNA-based Cancer Therapeutics.
  • 22 Jul 2026
  • Current pharmaceutical biotechnology
Evaluation of In vitro Antibacterial Efficacy of Terminalia catappa Leaf Extracts: A Selective Killing Approach for Disease Management in Recirculatory Aquaculture System.
  • 22 Jul 2026
  • Current pharmaceutical biotechnology
SIRT6, a New Hope in Liver Diseases: From Pathogenic Mechanisms to Therapeutic Strategies.
  • 22 Jul 2026
  • Current pharmaceutical biotechnology
Protection of Fulvic Acid Against 5-Fluorouracil-induced Intestinal Injury in Mice.
  • 27 Jul 2026
  • Current pharmaceutical biotechnology
Phytochemicals as Novel Antifungal Agents Against Candida species.
  • 25 Jul 2026
  • Current pharmaceutical biotechnology
Ultraviolet-A-Enhanced Antibacterial Activities on Gentamicin-Resistant Escherichia coli by Silver Nanorods Synthesized from Callistemon viminalis Leaf Extract.
  • 23 Jul 2026
  • Current pharmaceutical biotechnology
Challenges and Strategies in Advancing miRNA-based Cancer Therapeutics.
  • 22 Jul 2026
  • Current pharmaceutical biotechnology
Evaluation of In vitro Antibacterial Efficacy of Terminalia catappa Leaf Extracts: A Selective Killing Approach for Disease Management in Recirculatory Aquaculture System.
  • 22 Jul 2026
  • Current pharmaceutical biotechnology
SIRT6, a New Hope in Liver Diseases: From Pathogenic Mechanisms to Therapeutic Strategies.
  • 22 Jul 2026
  • Current pharmaceutical biotechnology

FAQs on Current Pharmaceutical Biotechnology